Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.44 - $0.89 $11 - $22
25 New
25 $0
Q3 2022

Nov 14, 2022

BUY
$0.26 - $46.35 $0 - $139
3 New
3 $0
Q2 2022

Aug 11, 2022

SELL
$2.14 - $3.43 $111 - $178
-52 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$2.2 - $6.01 $114 - $312
52 New
52 $0
Q4 2021

Feb 10, 2022

SELL
$6.0 - $9.92 $2,502 - $4,136
-417 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$6.98 - $12.03 $2,910 - $5,016
417 New
417 $3,000

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $371M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.